Presentation of the project OptoPath™
A rodent platform entirely dedicated to innovation in experimental psychopathology
OptoPath™ combines the expertise of neurobiologists, electrophysiologists and experimental psychologists for the identification of new therapeutic targets against 4 major psychological disorders: Addiction, Obesity, PTSD/Anxiety-related disorders and Memory deficits.
Combining innovative animal models and cutting-edge technologies, OptoPath provides :
- Equipment marketing through its industrial partner Imetronic
- A large range of in vivo assays to evaluate the safety/therapeutic effects of novel drugs in the context of 4 major psychopathologies:
|
|
 |
 |
|
| PTSD-ANXIETY | MEMORY DEFICITS |
450
M2
34
Neurobiology
units
units
116
Behavioral
units
units
+40
Users